News & Insights
NuView Life Sciences Provides Corporate Update On NV-VPAC1 Theranostic for Breast Cancer 10.5.22
Advancements in Cancer Treatment -
Targeting VPAC1 Receptors for Imaging Glioblastoma
1.25.22
Research Article
Malignant glioblastoma (MG) is the most common primary tumor of the cerebral hemisphere [1]. Glioblastoma multiforme, among them, is highly malignant and present poor prognosis. Despite the advances in treatment of MG, the disease remains largely incurable [2, 3]. read more
Global Expansion -
NuView Life Sciences Creates Subsidiary for Latin American Market
11.7.21
Press Release
PARK CITY, UT NuView Life Sciences, Inc (“NuView”, the “company”), a clinical-stage oncology company focusing on innovative approaches to diagnose and treat cancers establishes NuView LATAM (“NV-LATAM”) in Mexico City.
read more
Sign up for important updates and announcements.
Sign up to receive instant updates
Contact Us
Contact Us
NuView Life Sciences, Inc
1314 E. Las Olas Blvd
Ft Lauderdale FL 33301